Dimerix

Dimerix Share Buybacks

The Share Buybacks of Dimerix (DXB.AX) as of Oct 11, 2026 is 7.55 M AUD. In the previous year, Share Buybacks was -1.40 M AUD — a change of -637.92% (higher).

Share Buybacks

7.55 MAUD

YoY

-637.92%

Last updated:

Share Buybacks of Dimerix is 2025 7.55 M AUD. Share Buybacks of Dimerix was 2024 -1.40 M AUD. It decreases by -637.92% higher compared to the previous year.

The Dimerix Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2018
-371,464.00 AUD
Jan 1, 2019
-441,406.00 AUD
Jan 1, 2020
-441,406.00 AUD
Jan 1, 2021
-1.24 M AUD
Jan 1, 2022
-1.24 M AUD
Jan 1, 2023
-444,614.00 AUD
Jan 1, 2024
-1.40 M AUD
Jan 1, 2025
7.55 M AUD
The Dimerix Share Buybacks history
YEARShare BuybacksYoY
7.55 MAUD-637.92%
-1.40 MAUD+215.55%
-444,614.00AUD-64.14%
-1.24 MAUD0.00%
-1.24 MAUD+180.92%
-441,406.00AUD0.00%
-441,406.00AUD+18.83%
-371,464.00AUD+190.06%
-128,063.00AUD+545.48%
-19,840.00AUD-65.51%
-57,532.00AUD-102.59%
2.22 MAUD—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Share Buybacks of Dimerix is 7.55 M AUD in 2025.

Share Buybacks of Dimerix changed from -1.40 M AUD to 7.55 M AUD, representing a -637.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Share Buybacks Dimerix since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Dimerix historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Dimerix

All Key Metrics — Dimerix